Santiago, Pablito C.

HRN: 26-78-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2025
CEFTRIAXONE 1G (VIAL)
03/11/2025
03/18/2025
IV
2 Gram
OD
Intra Abdominal Infections
Waiting Final Action 
03/19/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/19/2025
03/25/2025
IV
500mg
Q12h
CAPHR
Waiting Final Action 
03/19/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/19/2025
03/19/2025
IV
4.5 G
LD
Pneumonia
Waiting Final Action 
03/19/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/19/2025
03/26/2025
IV
2.25g
Q8H
Pneumonja
Waiting Final Action 
03/20/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/20/2025
03/27/2025
IV
4.5
Q8
CAP HR
Waiting Final Action 
03/21/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/21/2025
03/27/2025
TOPICAL
Apply
Tid
Ulce, Pressure
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: